Versigent (NYSE:VGNT) Upgraded at Argus

Argus upgraded shares of Versigent (NYSE:VGNT) to a strong-buy rating in a report released on Tuesday,Zacks.com reports.

Several other analysts have also recently weighed in on the stock. Morgan Stanley initiated coverage on shares of Versigent in a research report on Friday, May 8th. They set an “overweight” rating and a $51.00 price objective on the stock. Oppenheimer set a $50.00 target price on Versigent in a research note on Tuesday. Fox Advisors upgraded Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Wall Street Zen raised Versigent to a “hold” rating in a research note on Saturday, April 18th. Finally, Royal Bank Of Canada upped their price objective on Versigent from $34.00 to $41.00 and gave the stock a “sector perform” rating in a report on Monday, July 13th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $49.67.

Versigent Price Performance

Shares of Versigent stock opened at $40.89 on Tuesday. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88. The company’s 50 day moving average is $43.29.